Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Justina Januskiene
Institution:
European Medicines Agency
Observed institution:
European Medicines Agency
ORCID:
0000-0001-6758-650X
Observed ORCID:
0000-0001-6758-650X
OpenAlex ID:
A5007585086
What are the patients' and health care professionals' understanding and behaviors towards adverse drug reaction reporting and additional monitoring?
2020
·
Justina Januskiene
, Andrej Segec
, et al.
·
Pharmacoepidemiology and Drug Safety
·
25
Secondary malignancy of T-cell origin after CAR T-cell therapy: EMA’s conclusions from the evaluation of 38 suspected cases
2025
·
Philipp Berg
, Charlotte Bakker
, et al.
·
Gene Therapy
·
24
PDF
Geographical variation in reporting Interstitial Lung Disease as an adverse drug reaction: findings from an European Medicines Agency analysis of reports in EudraVigilance
2016
·
Luis Pinheiro
, Kevin Blake
, et al.
·
Pharmacoepidemiology and Drug Safety
·
17
Does additional monitoring status increase the reporting of adverse drug reaction s ? An interrupted time series analysis of EudraVigilance data
2020
·
Andrej Segec
, Jim Slattery
, et al.
·
Pharmacoepidemiology and Drug Safety
·
9
PDF
Show more works
View as search
Works count:
4
Citation count:
75
H-index:
4
I10-index:
3
Year
Topic
Type